Safety and efficacy outcomes in patients undergoing pulmonary vein isolation with second-generation cryoballoon

Creative Commons License

AYTEMİR K., GÜRSES K. M., YALÇIN M. U., KOÇYİĞİT D., Dural M., EVRANOS B., ...More

EUROPACE, vol.17, no.3, pp.379-387, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 17 Issue: 3
  • Publication Date: 2015
  • Doi Number: 10.1093/europace/euu273
  • Journal Name: EUROPACE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.379-387
  • Hacettepe University Affiliated: Yes

Abstract

Aims The second-generation cryoballoon (Arctic Front Advance (TM)) (Arc-Adv-CB) has a redesigned injection system which distributes the refrigerant homogenously to the frontal balloon surface. The aim of this study was to compare the efficacy and safety of the Arc-Adv-CB and its predecessor (Arctic Front (TM)) (Arc-CB) in patients who underwent pulmonary vein isolation (PVI) for atrial fibrillation (AF).